{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:34:18Z","timestamp":1792611258374,"version":"4.5.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jhep.2020.08.009","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T00:26:36Z","timestamp":1599351996000},"page":"200-219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium"],"prefix":"10.1016","volume":"74","author":[{"given":"Elsa","family":"Sol\u00e0","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Pose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8782-1124","authenticated-orcid":false,"given":"Daniela","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9356-5830","authenticated-orcid":false,"given":"Salvatore","family":"Piano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-3936","authenticated-orcid":false,"given":"Macarena","family":"Simon-Talero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Uschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koos","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3219-6963","authenticated-orcid":false,"given":"Giacomo","family":"Zaccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Alessandria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-7799","authenticated-orcid":false,"given":"Ulrich","family":"Beuers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1439-056X","authenticated-orcid":false,"given":"Paolo","family":"Caraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Francoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar P.","family":"Mookerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7028-3881","authenticated-orcid":false,"given":"Jonel","family":"Trebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7355-7913","authenticated-orcid":false,"given":"Ferran","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2800-9923","authenticated-orcid":false,"given":"Sara","family":"Montagnese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9598-4932","authenticated-orcid":false,"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1518-4020","authenticated-orcid":false,"given":"Ruben","family":"Hernaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4024-677X","authenticated-orcid":false,"given":"Marko","family":"Korenjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6931-3158","authenticated-orcid":false,"given":"Hugh","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3421-937X","authenticated-orcid":false,"given":"Juan G.","family":"Abraldes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Gin\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sol\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Pich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Graupera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Napoleone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Juanola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Avitabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fabrellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Carol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Palacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Aban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lanzillotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Nicolao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.T.","family":"Chiappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Esnault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Forner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Graf-Dirmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Helder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"P\u00e9rez-Guasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2020.08.009_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D'Amico","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.1840070124","article-title":"Compensated cirrhosis: natural history and prognostic factors","volume":"7","author":"Gin\u00e9s","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib3","first-page":"S0168","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"24","author":"Trebicka","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.30182","article-title":"Preemptive-TIPS improves outcome in high-risk variceal bleeding: an observational study","volume":"69","author":"Hern\u00e1ndez-Gea","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib6","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1053\/j.gastro.2016.01.004","article-title":"Addition of simvastatin to standard therapy for the prevention of variceal rebleeding does not reduce rebleeding but increases survival in patients with cirrhosis","volume":"150","author":"Abraldes","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.gastro.2007.06.065","article-title":"Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis","volume":"133","author":"Fern\u00e1ndez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib8","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial","volume":"69","author":"Sol\u00e0","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib9","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1053\/j.gastro.2018.08.026","article-title":"Effects of long-term norfloxacin therapy in patients with advanced cirrhosis","volume":"155","author":"Moreau","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib11","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial","volume":"391","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.08.009_bib12","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep4.1342","article-title":"Looking into the crystal ball: predicting the future challenges of fibrotic NASH treatment","volume":"3","author":"Alkhouri","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2020.08.009_bib13","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.29607","article-title":"Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science","volume":"67","author":"Siddiqui","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib14","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/hep.30672","article-title":"Defining improvement in nonalcoholic steatohepatitis for treatment trial endpoints: recommendations from the Liver Forum","volume":"70","author":"Cheung","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-0036-1597891","article-title":"The design of clinical trials in portal hypertension","volume":"37","author":"Abraldes","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.08.009_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/hep.30314","article-title":"Prioritization of therapeutic targets and trial design in cirrhotic portal hypertension","volume":"69","author":"Abraldes","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib18","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jhep.2017.10.020","article-title":"Clinical states of cirrhosis and competing risks","volume":"68","author":"D'Amico","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s12072-017-9808-z","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"12","author":"D'Amico","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2020.08.009_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1055\/s-0038-1676805","article-title":"Child-pugh classification: time to abandon?","volume":"39","author":"Kok","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2020.08.009_bib21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"10.1016\/j.jhep.2020.08.009_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840040313","article-title":"Prognostic value of Child-Turcotte criteria in medically treated cirrhosis","volume":"4","author":"Christensen","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3109\/00365521.2012.661759","article-title":"Incidence, etiology and mortality of cirrhosis: a population-based cohort study","volume":"47","author":"Fialla","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.08.009_bib24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jhep.2013.09.027","article-title":"1 and 5 year survival estimates for people with cirrhosis of the liver in England, 1998-2009: a large population study","volume":"60","author":"Ratib","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jhep.2017.07.008","article-title":"Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis","volume":"67","author":"Piano","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib26","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S2468-1253(19)30320-6","article-title":"Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"5","author":"Pose","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.amjcard.2006.08.065","article-title":"A\u00a0propensity matched study of New York heart association class and natural history end points in heart failure","volume":"99","author":"Ahmed","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jhep.2020.08.009_bib30","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/thoraxjnl-2013-203270","article-title":"GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway","volume":"68","author":"Leivseth","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jhep.2020.08.009_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S2352-3018(17)30066-8","article-title":"Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies","volume":"4","author":"Trickey","year":"2017","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jhep.2020.08.009_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QCO.0b013e32835ba6b1","article-title":"Life expectancy living with HIV: recent estimates and future implications","volume":"26","author":"Nakagawa","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jhep.2020.08.009_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/hiv.12600","article-title":"Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0","volume":"19","author":"Ryom","year":"2018","journal-title":"HIV Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(17)32366-8","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Afshin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.08.009_bib36","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2016.06.018","article-title":"Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide","volume":"65","author":"Stein","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib37","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease","volume":"66","author":"Lackner","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib38","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2019.12.023","article-title":"Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32","volume":"72","author":"Degr\u00e9","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib39","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.24596","article-title":"Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption","volume":"54","author":"Staufer","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1530-0277.2012.01855.x","article-title":"Sensitivity and specificity of urinary ethyl glucuronide and ethyl sulfate in liver disease patients","volume":"37","author":"Stewart","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2020.08.009_bib41","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1111\/acer.12442","article-title":"Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease","volume":"38","author":"Stewart","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2020.08.009_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib43","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"EASL clinical practice guidelines: management of alcohol-related liver disease","volume":"69","author":"Thursz","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.08.009_bib45","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ajg.2011.425","article-title":"Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors","volume":"107","author":"Shiina","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.08.009_bib47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2012.09.020","article-title":"Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors","volume":"58","author":"Kim","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib48","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2020.08.009_bib49","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib50","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A\u00a0meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib51","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1053\/j.gastro.2017.07.016","article-title":"Effects of all-oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C Virus-associated cirrhosis","volume":"153","author":"Lens","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/hep.30885","article-title":"Changes in hepatic venous pressure gradient predict hepatic decompensation in patients who achieved sustained virologic response to interferon-free therapy","volume":"71","author":"Mandorfer","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2020.05.050","article-title":"Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension","author":"Lens","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib54","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/00365520410006350","article-title":"Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit","volume":"39","author":"Bell","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.08.009_bib55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0676.2003.01804.x","article-title":"Five-year survival predictive factors in patients with excessive alcohol intake and cirrhosis. Effect of alcoholic hepatitis, smoking and abstinence","volume":"23","author":"Pessione","year":"2003","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.08.009_bib56","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MOT.0000000000000643","article-title":"Geographic inequity in transplant access","volume":"24","author":"Lynch","year":"2019","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.jhep.2020.08.009_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/hep.27283","article-title":"Excess mortality on the liver transplant waiting list: unintended policy consequences and model for end-stage liver disease (MELD) inflation","volume":"61","author":"Northup","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib58","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM200006083422303","article-title":"A\u00a0comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites","volume":"342","author":"R\u00f6ssle","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib59","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garc\u00eda-Pag\u00e1n","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib60","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1016\/j.cgh.2019.03.042","article-title":"Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival","volume":"17","author":"Trebicka","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib61","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2020.08.009_bib64","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","article-title":"Advanced liver disease study group the model for end-stage liver disease (MELD)","volume":"45","author":"Kamath","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib65","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","article-title":"Hyponatremia and mortality among patients on the liver-transplant waiting list","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib66","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.1016\/j.jhep.2020.08.009_bib67","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2014.11.012","article-title":"The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure","volume":"62","author":"Jalan","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib68","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/jhep.2003.50133","article-title":"Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis","volume":"37","author":"Abraldes","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to \u03b2-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib70","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2006.09.013","article-title":"Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review","volume":"131","author":"D'Amico","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/srep32341","article-title":"Characterization of inflammatory response in acute-on-chronic liver failure and relationship with prognosis","volume":"6","author":"Sol\u00e9","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2020.08.009_bib72","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2019.00476","article-title":"Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis","volume":"10","author":"Trebicka","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2020.08.009_bib73","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hep.30592","article-title":"Neutrophil gelatinase-associated lipocalin for assessment of acute kidney injury in cirrhosis: a prospective study","volume":"70","author":"Huelin","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib74","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gin\u00e8s","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib75","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/gast.2003.50088","article-title":"The North American study for the treatment of refractory ascites","volume":"124","author":"Sanyal","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-8278(03)00188-0","article-title":"Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety","volume":"39","author":"Santos","year":"2003","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib77","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/hep.20364","article-title":"Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites","volume":"40","author":"Salerno","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib78","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib79","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2010.02.036","article-title":"Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis","volume":"53","author":"Wong","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/gut.2008.176495","article-title":"Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial","volume":"59","author":"Angeli","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.08.009_bib81","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1365-2036.2010.04236.x","volume":"31","author":"Gin\u00e8s","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.08.009_bib82","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL clinical practice guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"Angeli","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib84","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.1997.v112.pm9041251","article-title":"The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts","volume":"112","author":"Sanyal","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib85","doi-asserted-by":"crossref","first-page":"816","DOI":"10.7326\/0003-4819-122-11-199506010-00002","article-title":"Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites","volume":"122","author":"Wong","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib86","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/hep.510280313","article-title":"Renal effects of transjugular intrahepatic portosystemic shunt in cirrhosis: comparison of patients with ascites, with refractory ascites, or without ascites","volume":"28","author":"Gerbes","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib87","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1136\/gutjnl-2011-300157","article-title":"Satavaptan Investigators Group Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity","volume":"61","author":"Wong","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.08.009_bib88","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.21193","article-title":"Factors associated with poor health-related quality of life of patients with cirrhosis","volume":"120","author":"Marchesini","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib89","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11136-018-1813-8","article-title":"Patients with refractory ascites treated with alfapump\u00ae system have better health-related quality of life as compared to those treated with large volume paracentesis: the results of a multicenter randomized controlled study","volume":"27","author":"Stepanova","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jhep.2020.08.009_bib90","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.25724","article-title":"Improvement in quality of life and decrease in large-volume paracentesis requirements with the automated low-flow ascites pump","volume":"26","author":"Wong","year":"2020","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.08.009_bib91","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-8278(96)80065-1","article-title":"Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial","volume":"25","author":"Lebrec","year":"1996","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib92","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jhep.2012.07.020","article-title":"Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema","volume":"57","author":"Sol\u00e0","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib93","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2013.04.023","article-title":"Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis","volume":"59","author":"Ahluwalia","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib94","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2010.02293.x","article-title":"Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration","volume":"30","author":"Guevara","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2020.08.009_bib95","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/lt.23860","article-title":"Effect of the pretransplant serum sodium concentration on outcomes following liver transplantation","volume":"20","author":"Leise","year":"2014","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2020.08.009_bib96","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation","volume":"130","author":"Londo\u00f1o","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib97","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2007.09.001","article-title":"Hyponatremia treatment guidelines 2007: expert panel recommendations","volume":"120","author":"Verbalis","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib98","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF01095898","article-title":"Prognostic value of spontaneous hyponatremia in cirrhosis with ascites","volume":"21","author":"Arroyo","year":"1976","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.jhep.2020.08.009_bib99","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/hep.21412","article-title":"CAPPS investigators hyponatremia in cirrhosis: results of a patient population survey","volume":"44","author":"Angeli","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib100","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.22293","article-title":"Effects of satavaptan, a selective vasopressin V2 receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial","volume":"48","author":"Gin\u00e8s","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib101","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.22846","article-title":"Impact of pretransplant hyponatremia on outcome following liver transplantation","volume":"49","author":"Yun","year":"2009","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2020.08.009_bib102","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.amjmed.2016.09.011","article-title":"Limited efficacy of tolvaptan in patients with cirrhosis and severe hyponatremia: real-life experience","volume":"130","author":"Pose","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib103","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jhep.2014.05.042","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European association for the study of the liver and the American\u00a0Association for the Study of Liver Diseases","volume":"61","author":"Vilstrup","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib104","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"C\u00e1rdenas","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib106","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1681\/ASN.2009080857","article-title":"Oral tolvaptan is safe and effective in chronic hyponatremia","volume":"21","author":"Berl","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jhep.2020.08.009_bib107","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.jhep.2020.08.009_bib108","doi-asserted-by":"crossref","first-page":"756","DOI":"10.23736\/S0375-9393.20.14120-8","article-title":"Osmotic demyelination sindrome: epidemiology, cause and management. Are patients with end stage liver disease a special risk group?","volume":"86","author":"Verbeek","year":"2020","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jhep.2020.08.009_bib109","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn\u2013Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhep.2020.08.009_bib110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41572-018-0022-7","article-title":"Hepatorenal syndrome","volume":"4","author":"Gin\u00e8s","year":"2018","journal-title":"Nat Rev Dis Prim"},{"issue":"4","key":"10.1016\/j.jhep.2020.08.009_bib111","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib112","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: a step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib113","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","article-title":"Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis","volume":"57","author":"Fagundes","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib114","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2020.08.009_bib115","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib116","doi-asserted-by":"crossref","first-page":"e0128145","DOI":"10.1371\/journal.pone.0128145","article-title":"Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis","volume":"10","author":"Ariza","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.08.009_bib117","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","article-title":"Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis","volume":"15","author":"Puthumana","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2020.08.009_bib119","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/j.cgh.2018.01.035","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"6","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib120","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib121","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib122","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib123","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2020.08.009_bib124","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1053\/j.gastro.2016.02.026","article-title":"Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1","volume":"150","author":"Boyer","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib125","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/j.gastro.2006.07.010","article-title":"Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage","volume":"131","author":"Fern\u00e1ndez","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib126","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/hep.1840120416","article-title":"Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial","volume":"12","author":"Gin\u00e9s","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib127","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1136\/gutjnl-2017-314240","article-title":"Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis","volume":"67","author":"Fern\u00e1ndez","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.08.009_bib128","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.14309\/ajg.0000000000000280","article-title":"Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis","volume":"114","author":"Bajaj","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.08.009_bib129","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2008","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jhep.2020.08.009_bib130","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1136\/gutjnl-2017-314324","article-title":"Assessment of sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections","volume":"67","author":"Piano","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.08.009_bib131","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s00134-017-4802-4","article-title":"Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net","volume":"43","author":"Timsit","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib132","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/ajg.2017.253","article-title":"Predictors of early readmission in patients with cirrhosis after the resolution of bacterial infections","volume":"112","author":"Piano","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2020.08.009_bib133","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jhep.2016.08.006","article-title":"The challenges of multi-drug-resistance in hepatology","volume":"65","author":"Fern\u00e1ndez","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib134","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12072-017-9812-3","article-title":"Hepatic encephalopathy: a critical current review","volume":"12","author":"Hadjihambi","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2020.08.009_bib136","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2036.2011.04590.x","article-title":"Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement","volume":"33","author":"Bajaj","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2020.08.009_bib137","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.29146","article-title":"The animal naming test: an easy tool for the assessment of hepatic encephalopathy","volume":"66","author":"Campagna","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib138","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy: a double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib139","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jhep.2014.09.005","article-title":"Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure","volume":"62","author":"Romero-G\u00f3mez","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib141","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/hep.30534","article-title":"Prognostic role of ammonia in patients with cirrhosis","volume":"70","author":"Shalimar","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib142","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1053\/j.gastro.2018.01.028","article-title":"Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis","volume":"154","author":"Sim\u00f3n-Talero","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.jhep.2020.08.009_bib143","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2019.12.021","article-title":"Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis","volume":"72","author":"Praktiknjo","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib144","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1053\/j.gastro.2011.06.053","article-title":"Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment","volume":"141","author":"Talwalkar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2020.08.009_bib145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: an update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2020.08.009_bib146","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2020.08.009_bib147","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jhep.2018.12.018","article-title":"Prevalence and short-term mortality of acute-on-chronic liver failure: a national cohort study from the USA","volume":"70","author":"Hernaez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib148","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2018.07.007","article-title":"Liver transplantation in patients with multiple organ failures: feasibility and outcomes","volume":"69","author":"Thuluvath","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib149","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jhep.2014.11.045","article-title":"Acute-on-chronic liver failure: a\u00a0new syndrome that will re-classify cirrhosis","volume":"62","author":"Arroyo","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib150","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/CCM.0000000000003369","article-title":"Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis","volume":"46","author":"Karvellas","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jhep.2020.08.009_bib151","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2020.08.009_bib152","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jhepr.2019.07.005","article-title":"Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation","volume":"1","author":"Zaccherini","year":"2019","journal-title":"JHEP Reports Innov Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib153","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2017.21903","article-title":"Guidelines for inclusion of patient-reported outcomes in clinical trial protocols the spirit-pro extension","volume":"319","author":"Calvert","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jhep.2020.08.009_bib154","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1023\/A:1026458604826","article-title":"Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?","volume":"6","author":"Stephens","year":"1997","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jhep.2020.08.009_bib155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/ctr.12426","article-title":"Predictors of quality of life in patients evaluated for liver transplantation","volume":"28","author":"Jara","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jhep.2020.08.009_bib156","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.cgh.2017.04.004","article-title":"The long winding road to transplant: how sarcopenia and debility impact morbidity and mortality on the waitlist","volume":"15","author":"Bhanji","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib157","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/lt.23495","article-title":"Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value","volume":"18","author":"Tandon","year":"2012","journal-title":"Liver Transpl"},{"issue":"10","key":"10.1016\/j.jhep.2020.08.009_bib158","doi-asserted-by":"crossref","first-page":"e0186990","DOI":"10.1371\/journal.pone.0186990","article-title":"Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2020.08.009_bib159","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","author":"Merli","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2020.08.009_bib160","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/jamasurg.2019.2845","article-title":"Association between liver transplant wait-list mortality and frailty based on body mass index","volume":"154","author":"Haugen","year":"2019","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.jhep.2020.08.009_bib161","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2020.03.029","article-title":"Changes in frailty are associated with waitlist mortality in patients with cirrhosis","volume":"73","author":"Lai","year":"2020","journal-title":"J\u00a0Hepatol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820305365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827820305365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:41:40Z","timestamp":1759174900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827820305365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0168827820305365"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2020.08.009","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2020.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association for the Study of the Liver. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}